Christopher Weir

Title: Christopher Weir: Innovator in Antibody Production

Introduction

Christopher Weir is an accomplished inventor based in New South Wales, Australia. He has made significant contributions to the field of immunology, particularly in the production of antibodies. His innovative work has the potential to impact the medical community positively.

Latest Patents

Christopher Weir holds a patent for a method of producing IgG1 subclass antibodies reactive to the surface of Cryptosporidium oocysts. The patent outlines a detailed process that includes separating a portion of the Cryptosporidium oocyst wall from the internal sporozoites to create an oocyst-wall preparation. The method further involves treating this preparation to obtain an oocyst antigen capable of eliciting a detectable IgG1 immune response in an animal. The process culminates in immunizing an animal with the oocyst antigen preparation to elicit an IgG1 immune response and obtaining IgG1 antibodies reactive to the surface of Cryptosporidium oocysts.

Career Highlights

Throughout his career, Christopher Weir has focused on advancing the understanding of immune responses and antibody production. His work has led to the development of innovative methods that enhance the efficacy of antibody generation, which is crucial for therapeutic applications.

Collaborations

Christopher has collaborated with notable professionals in his field, including Graham Vesey and Keith Leslie Williams. These collaborations have enriched his research and contributed to the advancement of immunological studies.

Conclusion

Christopher Weir is a notable inventor whose work in antibody production showcases his dedication to advancing medical science. His innovative methods have the potential to lead to significant breakthroughs in immunology.